New Harbor Venture Partners

New Harbor Venture Partners is a US venture firm with a website and LinkedIn presence consistent with a small or boutique investor active across early and growth-stage opportunities. The naming convention and limited disclosure are consistent with a regional or specialist manager rather than a high-velocity coastal generalist. Healthcare exposure is unstated and likely selective; expect openness to digital health, healthtech, and tech-enabled services in healthcare where the company has revenue traction and a credible scaling path, but limited specialist clinical or regulatory diligence capacity unless the partner team has explicit healthcare backgrounds. AI focus is unstated and likely subordinate to deal type. Without disclosed stage or check data, anchor expectations to a small generalist vehicle: Seed through Series B participation with checks plausibly in the USD 500K to USD 3M range, more often as a co-investor than a lead. This is the wrong door for capital-intensive therapeutics or for AI-first founders looking for a thesis-aligned conviction lead. It is a plausible fit for revenue-stage healthcare software founders who want a generalist partner to round out a syndicate. Entry path is the website contact and LinkedIn outreach; warm introductions from the firm’s network raise reply rates. Founders should be specific about what fits the firm’s plausible deal profile and clarify their stage, traction, and syndicate strategy early in the conversation.